GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gian Life Care Ltd (BOM:542918) » Definitions » EPS (Diluted)

Gian Life Care (BOM:542918) EPS (Diluted) : ₹3.79 (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Gian Life Care EPS (Diluted)?

Gian Life Care's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was ₹0.12. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹3.79.

Gian Life Care's EPS (Basic) for the three months ended in Sep. 2024 was ₹0.12. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹3.79.

Gian Life Care's EPS without NRI for the three months ended in Sep. 2024 was ₹0.12. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was ₹3.79.

During the past 12 months, Gian Life Care's average EPS without NRIGrowth Rate was 182.80% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 27.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Gian Life Care's highest 3-Year average EPS without NRI Growth Rate was 27.50% per year. The lowest was -10.20% per year. And the median was 8.65% per year.


Gian Life Care EPS (Diluted) Historical Data

The historical data trend for Gian Life Care's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gian Life Care EPS (Diluted) Chart

Gian Life Care Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EPS (Diluted)
Get a 7-Day Free Trial 1.42 1.95 4.23 1.03 4.02

Gian Life Care Quarterly Data
Mar19 Jun19 Sep19 Mar20 Sep20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 1.50 2.07 0.10 0.12

Competitive Comparison of Gian Life Care's EPS (Diluted)

For the Diagnostics & Research subindustry, Gian Life Care's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gian Life Care's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Gian Life Care's PE Ratio distribution charts can be found below:

* The bar in red indicates where Gian Life Care's PE Ratio falls into.


;
;

Gian Life Care EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Gian Life Care's Diluted EPS for the fiscal year that ended in Mar. 2024 is calculated as

Diluted EPS (A: Mar. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(41.525-0)/10.342
=4.02

Gian Life Care's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1.173-0)/9.775
=0.12

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gian Life Care  (BOM:542918) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Gian Life Care EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Gian Life Care's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Gian Life Care Business Description

Traded in Other Exchanges
N/A
Address
7/216 (6) Swaroop Nagar, Infront of L-L.R. Hospital, Kanpur, UP, IND, 208002
Gian Life Care Ltd is an Indian firm engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. The company provides a broad range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention, and wellness diagnosis services to its patients and healthcare providers. Its customers include individual patients, hospitals, other healthcare providers, and corporate customers. Substantial revenue accrues from the Pathological Testing Fees. The Company has only one operating segment namely, Laboratories Pathological Investigations.

Gian Life Care Headlines

No Headlines